WallStSmart

Amrize Ltd (AMRZ)vsCRH PLC ADR (CRH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC ADR generates 217% more annual revenue ($37.45B vs $11.81B). CRH leads profitability with a 10.0% profit margin vs 10.0%. AMRZ appears more attractively valued with a PEG of 1.40. CRH earns a higher WallStSmart Score of 69/100 (B-).

AMRZ

Buy

55

out of 100

Grade: C-

Growth: 3.3Profit: 6.5Value: 7.3Quality: 5.8
Piotroski: 3/9

CRH

Strong Buy

69

out of 100

Grade: B-

Growth: 6.7Profit: 7.0Value: 10.0Quality: 7.5
Piotroski: 4/9Altman Z: 2.02
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMRZSignificantly Overvalued (-119.3%)

Margin of Safety

-119.3%

Fair Value

$26.88

Current Price

$56.12

$29.24 premium

UndervaluedFair: $26.88Overvalued
CRHUndervalued (+50.4%)

Margin of Safety

+50.4%

Fair Value

$257.87

Current Price

$106.05

$151.82 discount

UndervaluedFair: $257.87Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMRZ2 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$1.65B8/10

Generating 1.6B in free cash flow

CRH4 strengths · Avg: 8.3/10
Market CapQuality
$71.24B9/10

Large-cap with strong market position

Price/BookValuation
3.0x8/10

Reasonable price relative to book value

EPS GrowthGrowth
48.4%8/10

Earnings expanding 48.4% YoY

Free Cash FlowQuality
$2.09B8/10

Generating 2.1B in free cash flow

Areas to Watch

AMRZ4 concerns · Avg: 3.3/10
P/E RatioValuation
25.9x4/10

Moderate valuation

EPS GrowthGrowth
3.6%4/10

3.6% earnings growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-0.4%2/10

Revenue declined 0.4%

CRH1 concerns · Avg: 4.0/10
PEG RatioValuation
2.004/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : AMRZ

The strongest argument for AMRZ centers on Price/Book, Free Cash Flow. PEG of 1.40 suggests the stock is reasonably priced for its growth.

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, Price/Book, EPS Growth.

Bear Case : AMRZ

The primary concerns for AMRZ are P/E Ratio, EPS Growth, Piotroski F-Score.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio.

Key Dynamics to Monitor

CRH is growing revenue faster at 6.2% — sustainability is the question.

CRH generates stronger free cash flow (2.1B), providing more financial flexibility.

Monitor BUILDING MATERIALS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRH scores higher overall (69/100 vs 55/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Amrize Ltd

BASIC MATERIALS · BUILDING MATERIALS · USA

Amrize Ltd (AMRZ) is an innovative technology company at the forefront of the digital health and wellness sector, striving to transform healthcare delivery through advanced technologies and data-driven solutions. With a strong emphasis on enhancing patient outcomes and increasing healthcare accessibility, Amrize engages in extensive research and development to address the growing demand for scalable health solutions. The company’s strategic initiatives position it to play a pivotal role in the evolving landscape of healthcare, making it a critical player in the advancement of modern healthcare systems.

Visit Website →

CRH PLC ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Want to dig deeper into these stocks?